Stephen J. Peroutka
Keine laufenden Positionen mehr
Profil
Stephen J.
Peroutka was the founder of Spectra Biomedical, Inc. founded in 1993 where he held the title of President.
He also held former positions as President & Chief Executive Officer at Synergia Pharma, Inc. from 2003 to 2005, Director-Neuroscience Department at Genentech, Inc. from 1990 to 1993, Vice President-Clinical Research at Deltagen, Inc. from 2001 to 2002, Assistant Professor-Neurology & Pharmacology at Stanford University from 1984 to 1990, Chief Medical Officer & Executive Vice President at NeurogesX, Inc., and Chief Medical Officer at Collabra Pharma, Inc. from 2000 to 2001.
Dr. Peroutka's education history includes a doctorate from The Johns Hopkins University and an undergraduate degree from Cornell University.
Ehemalige bekannte Positionen von Stephen J. Peroutka
| Unternehmen | Position | Ende |
|---|---|---|
Synergia Pharma, Inc.
 Synergia Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synergia Pharma, Inc. develops clinical therapeutics. It offers therapeutics for the treatment of migraine and other neurological disorders. The company is headquartered in South San Francisco, CA | Präsident | 01.08.2005 |
| DELTAGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 |
| Collabra Pharma, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
Spectra Biomedical, Inc.
 Spectra Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Spectra Biomedical, Inc. operates as a biotechnology company that created to use a focused bit of genomic bioinformatics, centered on various neurological conditions. The company was founded by Stephen J. Peroutka on January 1, 1993 and is headquartered in Philadelphia, PA. | Gründer | 01.01.1999 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.1993 |
Ausbildung von Stephen J. Peroutka
| The Johns Hopkins University | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DELTAGEN INC. | Commercial Services |
| Private Unternehmen | 6 |
|---|---|
Synergia Pharma, Inc.
Synergia Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synergia Pharma, Inc. develops clinical therapeutics. It offers therapeutics for the treatment of migraine and other neurological disorders. The company is headquartered in South San Francisco, CA | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
| Collabra Pharma, Inc. | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Spectra Biomedical, Inc.
Spectra Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Spectra Biomedical, Inc. operates as a biotechnology company that created to use a focused bit of genomic bioinformatics, centered on various neurological conditions. The company was founded by Stephen J. Peroutka on January 1, 1993 and is headquartered in Philadelphia, PA. | Health Technology |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
